<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Few large or long-term series exist regarding the management of patients with <z:hpo ids='HP_0011645'>sinus of Valsalva aneurysms</z:hpo> or <z:mpath ids='MPATH_70'>fistulas</z:mpath> (SVAFs) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Between 1956 and 1997, 129 patients presented with a ruptured (64 cases; 49.6%) or nonruptured (65 cases; 50.4%) SVAF </plain></SENT>
<SENT sid="2" pm="."><plain>The patients included 88 men and 41 women, with a mean age of 39.1 years </plain></SENT>
<SENT sid="3" pm="."><plain>Associated findings included a history of <z:hpo ids='HP_0100584'>endocarditis</z:hpo> (42 cases; 32.6%), a <z:hpo ids='HP_0001647'>bicuspid aortic valve</z:hpo> (21 cases; 16.3%), a <z:hpo ids='HP_0001629'>ventricular septal defect</z:hpo> (15 cases; 11.6%), and <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e> (12 cases; 9.3%) </plain></SENT>
<SENT sid="4" pm="."><plain>Operative procedures included simple plication (61 cases; 47.3%), patch repair (52 cases; 40.3%), aortic root replacement (16 cases; 12.4%), and aortic valve replacement/repair (75 cases; 58.1%) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: There were five in-hospital <z:hpo ids='HP_0011420'>deaths</z:hpo> (3.9%): four due to preexisting <z:hpo ids='HP_0100806'>sepsis</z:hpo> and <z:hpo ids='HP_0100584'>endocarditis</z:hpo> and one that followed dehiscence of the repair in a patient with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Two patients (1.6%) had <z:hpo ids='HP_0001297'>strokes</z:hpo> during the early postoperative period </plain></SENT>
<SENT sid="7" pm="."><plain>The survivors were followed up for 661.1 patient-years (5.3 years/patient) </plain></SENT>
<SENT sid="8" pm="."><plain>The following late complications occurred: prosthetic valve malfunction (5 cases; 3.9%), prosthetic valve <z:hpo ids='HP_0100584'>endocarditis</z:hpo> (3 cases; 2.3%), SVAF recurrence (2 cases; 1.6%), <z:mp ids='MP_0005048'>thrombosis</z:mp> (1 case; 0.8%), and anticoagulation-related <z:mp ids='MP_0001914'>bleeding</z:mp> (1 case; 0.8%) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Resection and repair of SVAF entails an acceptably low operative risk and yields long-term freedom from symptoms </plain></SENT>
<SENT sid="10" pm="."><plain>Early, aggressive treatment is recommended to prevent <z:hpo ids='HP_0100584'>endocarditis</z:hpo> or lesional enlargement, which causes worse symptoms and necessitates more extensive repair </plain></SENT>
</text></document>